Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnVision Endoscopy is a private U.S. medical device company developing tools for gastrointestinal endoscopic surgery. Its lead product is the Image Guided Suturing System (IGSS), a low-cost, single-use device designed to attach to standard flexible endoscopes for tissue approximation and endoluminal management of gastrointestinal defects. The company positions its technology as a simpler, lower-cost approach intended to expand access to advanced endoscopic closure procedures for gastroenterologists and surgeons while reducing procedure burden and cost of care. Founded by Azadeh Khanicheh and Christopher Thompson, the company has been supported by startup grants, accelerator programs, and Massachusetts life sciences funding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnVision Endoscopy.